Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
81
天
Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi‐Regional Clinical Trials and Future Pathways
作者
Yosuke Kobayashi; Nobuko Matsushima; Noriyuki Takai; Daisuke Sato; Shinichiro Hoshino; Akihiro Ishiguro; Yasuo Iimura展开收起
作者单位
1. Pharmaceuticals and Medical Devices Agency Tokyo Japan; 2. Johnson & Johnson J&J Innovative Medicine Tokyo Japan; 3. Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association Tokyo Japan; 4. EPS Corporation Tokyo Japan; 5. Ministry of Health, Labour and Welfare Tokyo Japan; 6. Eli Lilly Japan K.K. Kobe Japan展开收起
100
天
Resolving CYP2D6 Structural Complexity with Long‐Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients
作者
Usa Boonyuen; Sirinyatorn Talukam; Beatriz Aira C. Jacob; Wayu Matphong; Kamonwan Chamchoy; Onrapak Reamtong; Nuntana Meesiripan; Junya Yamagishi; Matthew Phanchana; Chayanoot Rattadilok展开收起
作者单位
1. Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine Mahidol University Bangkok Thailand; 2. Princess Srisavangavadhana Faculty of Medicine Chulabhorn Royal Academy Bangkok Thailand; 3. National Cancer Institute Bangkok Thailand; 4. International Institute for Zoonosis Control Hokkaido University Hokkaido Japan展开收起
123
天
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin–Angiotensin System Inhibitors
作者
Katherine L. Crum; Muthiah Vaduganathan; Rishi J. Desai展开收起
作者单位
1. Department of Epidemiology Harvard T.H. Chan School of Public Health Boston Massachusetts USA; 2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA; 3. Division of Cardiovascular Medicine Brigham and Women's Hospital Boston Massachusetts USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天